SUCNR1
Succinate receptor 1
Also known as: GPR91, SUCR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BXA5
- Gene
- SUCNR1
- Ensembl
- ENSG00000198829
- Chromosome
- 3
- Canonical length
- 334 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a G-protein-coupled receptor for succinate, an intermediate molecule of the citric acid cycle. It is involved in the promotion of hematopoietic progenitor cell development, and it has a potential role in renovascular hypertension which has known correlations to renal failure, diabetes and atherosclerosis. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
334 residues, UniProt reviewed canonical sequence.
>Q9BXA5|SUCNR1
1 MLGIMAWNAT CKNWLAAEAA LEKYYLSIFY GIEFVVGVLG NTIVVYGYIF SLKNWNSSNI
61 YLFNLSVSDL AFLCTLPMLI RSYANGNWIY GDVLCISNRY VLHANLYTSI LFLTFISIDR
121 YLIIKYPFRE HLLQKKEFAI LISLAIWVLV TLELLPILPL INPVITDNGT TCNDFASSGD
181 PNYNLIYSMC LTLLGFLIPL FVMCFFYYKI ALFLKQRNRQ VATALPLEKP LNLVIMAVVI
241 FSVLFTPYHV MRNVRIASRL GSWKQYQCTQ VVINSFYIVT RPLAFLNSVI NPVFYFLLGD
301 HFRDMLMNQL RHNFKSLTSF SRWAHELLLS FREKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SUCNR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- kidney: 37 nTPM
- thyroid gland: 8.8 nTPM
- bone marrow: 7.6 nTPM
- stomach: 7.4 nTPM
- spleen: 6.6 nTPM
- liver: 4.9 nTPM
Single-cell type
- kupffer cells: 121 nCPM
- platelets: 95 nCPM
- neutrophil progenitors: 75 nCPM
- microglia: 34 nCPM
- hofbauer cells: 33 nCPM
- macrophages: 29 nCPM
Immune cell
- plasmacytoid DC: 0.5 nTPM
- eosinophil: 0.4 nTPM
- non-classical monocyte: 0.4 nTPM
- intermediate monocyte: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- thalamus: 1.1 nTPM
- medulla oblongata: 0.7 nTPM
- pons: 0.6 nTPM
- hypothalamus: 0.5 nTPM
- white matter: 0.5 nTPM
- midbrain: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- energy homeostasis
- G protein-coupled receptor signaling pathway
- glucose homeostasis
- macrophage activation involved in immune response
- positive regulation of chemotaxis
- positive regulation of inflammatory response
- regulation of angiotensin metabolic process
- renin secretion into blood stream
- response to calcium ion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SUCNR1 as an antibody target. Whether an autoantibody or antibody against SUCNR1 could matter depends on whether native SUCNR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SUCNR1 is annotated at the cell surface, where native SUCNR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SUCNR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...